Wildon Farwell, Chief Medical Officer at Dyne Therapeutics, Inc. (DYN), sold 4,264 shares at $31.27 ($133K) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Scheduled sale ($133k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.27 | 1,008 | $32K | 23.6% |
| 2 | $31.27 | 1,628 | $51K | 38.2% |
| 3 | $31.27 | 1,628 | $51K | 38.2% |
| Total | $31.27 avg | 4,264 | $133K | 100% |
| Filing → |
| DYN | SELL | 2024-03-12 | $67K | — | Filing → |
| DYN | SELL | 2024-03-11 | $472K | — | Filing → |
| DYN | SELL | 2024-02-28 | $10K | — | Filing → |